Header Logo

Connection

Eric Smith to Schizophrenia

This is a "connection" page, showing publications Eric Smith has written about Schizophrenia.
Connection Strength

1.001
  1. Gouse BM, Chang AL, Smith EG. Effect Size and Blinding in Lumateperone Trial. JAMA Psychiatry. 2020 06 01; 77(6):650-651.
    View in: PubMed
    Score: 0.586
  2. Jasuja GK, Reisman JI, Miller DR, Ansara ED, Chiulli DL, Moore T, Ourth HL, Tran MH, Smith EG, Morreale AP, McCullough MM. Complexity of patients with mental healthcare needs cared for by mental health clinical pharmacist practitioners in Veterans Affairs. Am J Health Syst Pharm. 2024 May 24; 81(11):e289-e295.
    View in: PubMed
    Score: 0.193
  3. G?ren JL, Rose AJ, Engle RL, Smith EG, Christopher ML, Rickles NM, Semla TP, McCullough MB. Organizational Characteristics of Veterans Affairs Clinics With High and Low Utilization of Clozapine. Psychiatr Serv. 2016 11 01; 67(11):1189-1196.
    View in: PubMed
    Score: 0.111
  4. G?ren JL, Rose AJ, Smith EG, Ney JP. The Business Case for Expanded Clozapine Utilization. Psychiatr Serv. 2016 11 01; 67(11):1197-1205.
    View in: PubMed
    Score: 0.111
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.